We examined the effects of acteoside (1a), which was isolated from Orobanche minor, and its derivatives on the aggregation of a 42-mer amyloid β protein (Aβ42) in our search for anti-amyloidogenic compounds for Alzheimer's disease (AD) therapy. Acteoside (1a) strongly inhibited the aggregation of Aβ42 in a dose-dependent manner. The structure-activity relationship for acteoside (1a) and related compounds suggests the catechol moiety of phenylethanoid glycosides to be essential for this inhibitory activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1271/bbb.130101 | DOI Listing |
Publication Analysis
Top Keywords
inhibition amyloid
4
amyloid aggregation
4
acteoside
4
aggregation acteoside
4
acteoside phenylethanoid
4
phenylethanoid glycoside
4
glycoside examined
4
examined effects
4
effects acteoside
4
acteoside isolated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!